Study of combination immunosuppressive therapy in primary sclerosing cholangitis - A multicenter study for combination immunosuppressive therapy with mizoribine and azathioprine
Not Applicable
- Conditions
- Primary sclerosing cholangitis
- Registration Number
- JPRN-UMIN000029482
- Lead Sponsor
- Osaka General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with some history of hypersensitivity to Bredini, Imuran, or Azanin Tablets 2. WBC:<=3000/mm3 3. Pregnants or patients who desire pregnancy 4. Patients with severe allergy 5. Patients who are judged inappropriate by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method